LONG-TERM SAFETY OF TOPICAL CALCINEURIN INHIBITORS HAS NOT BEEN ESTABLISHED.
See full prescribing information for complete boxed warning.
- TRADE NAME: Elidel (Valeant)
- INDICATIONS: Second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis
- CLASS: Immunomodulator, Macrolactam
- HALF-LIFE: N/A
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Abatacept, Alcohol, Alefacept, Aprepitant, Azacitidine, Betamethasone, Cabazitaxel, Calcium channel blockers, Cimetidine, Conivaptan, CYP3A4 inhibitors, Darunavir, Delavirdine, Denileukin, Docetaxel, Efavirenz, Erythromycin, Fingolimod, Fluconazole, Gefitinib, Immunosuppressants, Indinavir, Itraconazole, Ketoconazole, Lapatinib, Leflunomide, Lenalidomide, Oxaliplatin, Pazopanib, Pemetrexed, Pralatrexate, Telithromycin, Temsirolimus, Triamcinolone, Voriconazole
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
